SCHEMBL23382829

SCHEMBL23382829

CCC1(OC(=O)c2ccc(C(=O)OC(c3ccccc3)C(F)(F)C(=O)O)cc2)CCCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.36
▸ KMT2A Q03164 5/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ ESR1 P03372 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ CTSK P43235 2/20 0.34
▸ CTSL P07711 1/20 0.34
▸ CTSS P25774 1/20 0.34
▸ MAPT P10636 3/20 0.33
▸ POLB P06746 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ PDCD1 Q15116 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23382830 0.99 FFAR1 (0.36) FFAR1KMT2AMEN1SMN1; SMN2NPSR1
SCHEMBL23382722 0.90 SLC6A2 (0.37) FFAR1KMT2AMEN1SMN1; SMN2NPSR1
SCHEMBL23382533 0.89 FFAR1 (0.39) FFAR1KMT2AMEN1SMN1; SMN2NPSR1
SCHEMBL23382723 0.89 SLC6A2 (0.39) FFAR1KMT2AMEN1SMN1; SMN2NPSR1
SCHEMBL23382527 0.89 FFAR1 (0.39) FFAR1KMT2AMEN1SMN1; SMN2NPSR1
SCHEMBL23382475 0.85 ESR1 (0.37) FFAR1KMT2AMEN1SMN1; SMN2NPSR1
SCHEMBL23382821 0.84 ESR1 (0.36) FFAR1KMT2AMEN1SMN1; SMN2NPSR1
SCHEMBL23382823 0.83 PDCD1 (0.36) FFAR1KMT2AMEN1SMN1; SMN2NPSR1
SCHEMBL23382831 0.83 PDCD1 (0.36) FFAR1KMT2AMEN1SMN1; SMN2NPSR1
SCHEMBL23382812 0.82 MEN1 (0.33) KMT2AMEN1SMN1; SMN2NPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 FFAR1 1497/4885KMT2A 2745/4885MEN1 3334/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 FFAR1 1497/4885KMT2A 2745/4885MEN1 3334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback